These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3439796)

  • 21. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.
    Meissner HC; Fulton DR; Groothuis JR; Geggel RL; Marx GR; Hemming VG; Hougen T; Snydman DR
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1655-8. PubMed ID: 8215279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
    Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B; Björkstén B
    Pediatrics; 1995 Apr; 95(4):500-5. PubMed ID: 7700748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin treatment for respiratory syncytial virus infection.
    Fuller H; Del Mar C
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004883. PubMed ID: 17054220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of respiratory syncytial virus diseases in hospitalized children in the district of Steyr 1984/85].
    Emhofer J; Ploier R; Popow-Kraupp T; Brunhuber W
    Padiatr Padol; 1988; 23(1):15-23. PubMed ID: 3260367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus.
    Dagan R; Landau D; Haikin H; Tal A
    Pediatr Infect Dis J; 1993 May; 12(5):381-6. PubMed ID: 8327298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic.
    Conrad DA; Christenson JC; Waner JL; Marks MI
    Pediatr Infect Dis J; 1987 Feb; 6(2):152-8. PubMed ID: 3562136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection.
    Garofalo R; Kimpen JL; Welliver RC; Ogra PL
    J Pediatr; 1992 Jan; 120(1):28-32. PubMed ID: 1731020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.
    Belshe RB; Van Voris LP; Mufson MA
    J Infect Dis; 1982 Mar; 145(3):311-9. PubMed ID: 7037983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats.
    Sami IR; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA
    J Infect Dis; 1995 Feb; 171(2):440-3. PubMed ID: 7844385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.
    Meddens MJ; Herbrink P; Lindeman J; van Dijk WC
    J Clin Microbiol; 1990 Jan; 28(1):152-5. PubMed ID: 2298874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bronchiolitis caused by respiratory syncytial virus in very young infants and transmitted maternal antibodies].
    Attree O; Tourangeau F; De Saint-Maur G; Alvarez-Vega M; Nicolas JC; Garbarg-Chenon A; Bricout F
    Arch Fr Pediatr; 1988 Dec; 45(10):791-3. PubMed ID: 3071286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.
    Janai HK; Stutman HR; Zaleska M; Rub B; Eyzaguirre M; Marks MI; Nussbaum E
    Pediatr Infect Dis J; 1993 Mar; 12(3):214-8. PubMed ID: 8451098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A lamb model for human respiratory syncytial virus infection.
    Lapin CD; Hiatt PW; Langston C; Mason E; Piedra PT
    Pediatr Pulmonol; 1993 Mar; 15(3):151-6. PubMed ID: 8327277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
    Verdijk P; van der Plas JL; van Brummelen EMJ; Jeeninga RE; de Haan CAM; Roestenberg M; Burggraaf J; Kamerling IMC
    Vaccine; 2020 Sep; 38(39):6088-6095. PubMed ID: 32718816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of rapid diagnosis of respiratory syncytial virus infection on management of small infants.
    Friedman AD; Naqvi SH; Arens MQ; Eyler MA
    Clin Pediatr (Phila); 1986 Aug; 25(8):404-6. PubMed ID: 3524958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
    Rodriguez WJ; Gruber WC; Groothuis JR; Simoes EA; Rosas AJ; Lepow M; Kramer A; Hemming V
    Pediatrics; 1997 Dec; 100(6):937-42. PubMed ID: 9374560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
    Wasserman RL; Greener BN; Mond J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1107-1119. PubMed ID: 29035131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease.
    Wang EE; Law BJ; Robinson JL; Dobson S; al Jumaah S; Stephens D; Boucher FD; McDonald J; Mitchell I; MacDonald NE
    Pediatrics; 1997 Mar; 99(3):E9. PubMed ID: 9099774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.